In Memory
Patient Information
Age: 38
Sex: Male
Diagnosed: 02/02
Location: Shamong, N.J.
Diagnosis: Stage IV DSRCT
Hospital - University of Pennsylvania Cancer Center
- Oncologist Edward Stadtmauer, MD
- Adult Oncology Surgeon: Dr. Douglas Fraker, University of Penn, Tel: 215-662-4000.
Passed Away: 10/19/05
[BACK]
Treatment
Surgery
- Debulking - 12 lbs tumor removed
- Surgery to remove 3 tumors
Chemotherapy
- First Line - P6 protocol - 7 rounds
- Rounds 1,2,3,6 Adriamycin, Vincristine, Cytoxin
- Rounds 4,5,7 Etoposide, Ifosfamide
- Second Line
- Gemcitabine (Gemzar)
- Third Line
- Targretin
- Fourth Line
- Targretin and ICE protocol : Ifosfamide, Carboplatin, Etoposide
- Fifth Line
- Targretin and ICE protocol , Thalidomide
- Sixth Line
- Adriamycin (Doxorubicin)(Doxil) and Thalidomide
- Seventh Line
- Adriamycin (Doxorubicin)(Doxil)
- Eighth Line
- Oral VP16, 300 mg of Thalidomide, Lupron shot
- Ninth Line
- Oral VP16 for two weeks
- Tenth Line
- Rapamycin 4mg daily. And 2x a week a Velcade push.
Stem Cell
- High Dose Chemo - Carboplatin & Theotepa
Other Drugs
- Lupron shot - Tumor tests positive for androgen receptor and negative for the c-kit receptor
Time Line
Date | Test | Treatment | Chemicals | Result |
---|---|---|---|---|
2/26/02 | 0 | Surgery | 0 | Debulking-12 pounds of tumor removed |
3/02 | 0 | 0 | 0 | 0 |
4/02 | 0 | Chemotherapy 1 | Adriamycin, Vincristine, Cytoxin | 0 |
4/02 | 0 | Chemotherapy 2 | Adriamycin, Vincristine, Cytoxin | 0 |
5/02 | 0 | Chemotherapy 3 | Adriamycin, Vincristine, Cytoxin | 0 |
6/02 | 0 | Chemotherapy 4 | Etoposide, Ifosfamide | 0 |
6/02 | 0 | Chemotherapy 5 | Etoposide, Ifosfamide | 0 |
7/02 | 0 | Chemotherapy 6 | Adriamycin, Vincristine, Cytoxin | 0 |
8/02 | 0 | Chemotherapy 7 | Etoposide, Ifosfamide | 0 |
9/29/02 | 0 | Stem cell Transplant | High dose chemotherapy - Carboplatin & Theotepa | 0 |
10/02 | 0 | 0 | 0 | 0 |
11/02 | 0 | 0 | 0 | 0 |
12/02 | 0 | 0 | 0 | 0 |
1/03 | 0 | 0 | 0 | 0 |
2/03 | 0 | 0 | 0 | 0 |
3/03 | 0 | 0 | 0 | 0 |
4/3/03 | 0 | Surgery | 0 | Remove 3 tumors |
0 | 0 | 0 | 0 | Tumor tests positive for androgen receptor and negative for the c-kit receptor |
5/10/03 | 0 | First Lupron shot | 0 | 0 |
6/03 | 0 | 0 | 0 | 0 |
7/03 | 0 | 0 | 0 | 0 |
8/03 | 0 | 0 | 0 | 0 |
9/03 | 0 | 0 | 0 | 0 |
10/03 | 0 | Chemotherapy | Gemcitabine | 0 |
11/03 | 0 | Chemotherapy | Gemcitabine | 0 |
12/03 | 0 | Chemotherapy | Gemcitabine | Tumor growth continues |
1/22/04 | 0 | Chemotherapy | Targretin | Shortness of breath. Tumors are now in the lungs |
2/04 | 0 | 0 | 0 | 0 |
3/10/04 | 0 | Chemotherapy | Targretin and ICE protocol: Ifosfamide, Carboplatin, Etoposide | 0 |
4/21/04 | 0 | Chemotherapy | Targretin and ICE protocol: Ifosfamide, Carboplatin, Etoposide | 0 |
5/10/04 | 0 | Chemotherapy | Targretin and ICE protocol: Ifosfamide, Carboplatin, Etoposide, Thalidomide | 0 |
6/16/04 | 0 | Chemotherapy | Targretin and ICE protocol: Ifosfamide, Carboplatin, Etoposide, Thalidomide | 0 |
7/22/04 | 0 | Chemotherapy | Targretin and ICE protocol: Ifosfamide, Carboplatin, Etoposide, Thalidomide | Dr. thought that Thalidomide kept disease stable for a while |
8/04 | 0 | 0 | 0 | 0 |
9/04 | 0 | 0 | 0 | 0 |
10/27/04 | 0 | Chemotherapy | Doxil and Thalidomide | 0 |
11/29/04 | 0 | Chemotherapy | Doxil | A lot of growth |
12/29/04 | 0 | Chemotherapy | Oral VP16, 300 mg of Thalidomide, Lupron shot | 0 |
1/12/05 | 0 | Chemotherapy | Oral VP16, 300 mg of Thalidomide, Lupron shot | 0 |
1/26/05 | 0 | Chemotherapy | Oral VP16 for two weeks | 0 |
2/05 | 0 | 0 | 0 | 0 |
3/05 | 0 | 0 | 0 | 0 |
4/21/05 | 0 | 0 | 0 | Some tumors around chest and heart smaller, tumor in abdomen got larger. |
5/27/05 | 0 | Chemotherapy | 4mg of Rapamycin daily and 2x aweek avelcade push | 0 |
6/05 | 0 | 0 | 0 | 0 |
7/05 | 0 | 0 | 0 | 0 |
8/05 | 0 | 0 | 0 | 0 |
9/05 | 0 | 0 | 0 | 0 |
10/19/05 | 0 | 0 | 0 | Passed Away |
45
[BACK]
Community content is available under CC-BY-SA unless otherwise noted.